Evidence map›Paper›PMID 20411674›Full record

ArticleJournal of health, population, and nutrition2010

Phenotypic and genetic characterization of antimicrobial profiles of Helicobacter pylori strains in Cuba.

Rafael Llanes, Claudia Soria, Shigeo Nagashima, Nobumichi Kobayashi, Angela Gala, Daymi Guzmán, Onelkis Feliciano, Lidunka Valdés, Oderay Gutiérrez, Heriberto Fernández and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of health, population, and nutrition, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Rafael LlanesMicrobiology, Clinical and Epidemiology Branch, Institute Pedro Kouri, Havana, Cuba. llanes@ipk.sld.cu
Claudia Soria
Shigeo Nagashima
Nobumichi Kobayashi
Angela Gala
Daymi Guzmán
Onelkis Feliciano
Lidunka Valdés
Oderay Gutiérrez
Heriberto Fernández
Alina Llop
Akihiro Wada
Instituto de Medicina Tropical “Pedro Kourí” · CUSapporo Medical University · JPAustral University of Chile · CLNagasaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study evaluated the antibiotic resistance patterns of Helicobacter pylori strains against metronidazole and clarithromycin in a hospital in Havana, Cuba. Eighty-five percent, 22.5%, and 10% of 40 H. pylori strains investigated were resistant to metronidazole, ciprofloxacin, and clarithromycin respectively but all were susceptible to amoxicillin and tetracycline. RdxA truncation was found only in metronidazole-resistant strains. In such strains, reported are eight and two novel mutations in the rdxA and frxA genes respectively. Two-point mutations in the 23S rRNA genes of clarithromycin-resistant strains were detected. A high prevalence of metronidazole resistance was found in Cuban H. pylori strains. Mutations in the rdxA gene may contribute more significantly than frxA gene to the high level of resistance to metronidazole. This study supports the need to continue monitoring the antibiotic susceptibility in H. pylori in Cuba to guide the treatment of such infection.

Indexed as

AdultAgedAge FactorsAmoxicillinAnti-Bacterial AgentsAnti-Infective AgentsCiprofloxacinClarithromycinCubaDrug Resistance, BacterialFemaleHelicobacter pyloriHumansMaleMetronidazoleMicrobial Sensitivity TestsAmoxicillinAnti-Bacterial AgentsAnti-Infective AgentsCiprofloxacinClarithromycinMetronidazoleTetracycline

Identifiers

PMID20411674
PMCPMC2980873
OpenAlexW2107739367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.